Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
出版年份 2012 全文链接
标题
Risk of Heart Failure in Breast Cancer Patients After Anthracycline and Trastuzumab Treatment: A Retrospective Cohort Study
作者
关键词
-
出版物
JNCI-Journal of the National Cancer Institute
Volume 104, Issue 17, Pages 1293-1305
出版商
Oxford University Press (OUP)
发表日期
2012-09-05
DOI
10.1093/jnci/djs317
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Validity of Eight Integrated Healthcare Delivery Organizations' Administrative Clinical Data to Capture Breast Cancer Chemotherapy Exposure
- (2012) T. Delate et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Sequential Versus Concurrent Trastuzumab in Adjuvant Chemotherapy for Breast Cancer
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31
- (2011) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials
- (2010) Lesley A Smith et al. BMC CANCER
- First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) Trial
- (2010) Michael Untch et al. JOURNAL OF CLINICAL ONCOLOGY
- Longer-Term Assessment of Trastuzumab-Related Cardiac Adverse Events in the Herceptin Adjuvant (HERA) Trial
- (2010) Marion Procter et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent Adjudication of Symptomatic Heart Failure With the Use of Doxorubicin and Cyclophosphamide Followed by Trastuzumab Adjuvant Therapy: A Combined Review of Cardiac Data From the National Surgical Adjuvant Breast and Bowel Project B-31 and the North Central Cancer Treatment Group N9831 Clinical Trials
- (2010) Stuart D. Russell et al. JOURNAL OF CLINICAL ONCOLOGY
- Uncertainty in Assessing Value of Oncology Treatments
- (2010) C. D. Mullins et al. ONCOLOGIST
- Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring
- (2009) A L Jones et al. BRITISH JOURNAL OF CANCER
- Cardiac toxicity associated with anthracycline-containing chemotherapy in older women with breast cancer
- (2009) Xianglin L. Du et al. CANCER
- Minimizing Cardiotoxicity While Optimizing Treatment Efficacy with Trastuzumab: Review and Expert Recommendations
- (2009) M. Martin et al. ONCOLOGIST
- Cardiac Management During Adjuvant Trastuzumab Therapy: Recommendations of the Canadian Trastuzumab Working Group
- (2008) John Mackey Current Oncology
- Cardiac Safety Analysis of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With or Without Trastuzumab in the North Central Cancer Treatment Group N9831 Adjuvant Breast Cancer Trial
- (2008) Edith A. Perez et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started